Journey Strategic Wealth LLC Buys Shares of 3,839 CVS Health Corporation $CVS

Journey Strategic Wealth LLC acquired a new stake in shares of CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,839 shares of the pharmacy operator’s stock, valued at approximately $265,000.

Other institutional investors have also added to or reduced their stakes in the company. FineMark National Bank & Trust raised its holdings in CVS Health by 1.7% during the 2nd quarter. FineMark National Bank & Trust now owns 9,576 shares of the pharmacy operator’s stock valued at $661,000 after acquiring an additional 157 shares during the period. Hazlett Burt & Watson Inc. boosted its holdings in shares of CVS Health by 10.9% in the second quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock worth $117,000 after acquiring an additional 165 shares during the period. Williams Financial LLC raised its stake in shares of CVS Health by 2.5% during the 2nd quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock valued at $478,000 after purchasing an additional 167 shares during the period. Hemington Wealth Management raised its stake in shares of CVS Health by 33.7% during the 1st quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock valued at $46,000 after purchasing an additional 172 shares during the period. Finally, Sunpointe LLC lifted its holdings in CVS Health by 4.0% during the 2nd quarter. Sunpointe LLC now owns 4,760 shares of the pharmacy operator’s stock worth $328,000 after purchasing an additional 185 shares in the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CVS has been the subject of a number of recent analyst reports. Zacks Research lowered CVS Health from a “strong-buy” rating to a “hold” rating in a report on Monday, September 8th. Jefferies Financial Group boosted their price objective on shares of CVS Health from $92.00 to $98.00 in a research note on Thursday, October 30th. Piper Sandler upped their target price on shares of CVS Health from $81.00 to $99.00 in a report on Friday, October 31st. Argus raised their price target on shares of CVS Health from $80.00 to $91.00 and gave the company a “buy” rating in a report on Tuesday, November 4th. Finally, Wolfe Research upped their price target on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a report on Monday, September 22nd. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $89.41.

CVS Health Stock Down 0.2%

Shares of NYSE:CVS opened at $77.90 on Tuesday. The firm has a fifty day moving average of $78.21 and a 200 day moving average of $70.38. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. The firm has a market capitalization of $98.89 billion, a PE ratio of 205.01, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company’s revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.4%. The ex-dividend date was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.